Clinical Trial Update: Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating inhibitors of Angiotensin II in proteinuric IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Angiotensin II inhibitors (angiotensin II receptor blockers and/or ACE inhibitors)

Snippet

Sponsor: University Magna Graecia | Conditions: IGA Glomerulonephritis | Phase 4 | Status: COMPLETED